AMNEAL PHARMACEUTICALS, INC. Item 5.07 Submission of Matters to a Vote of Security Holders.
Amneal Pharmaceuticals, Inc. (the "Company") held its 2022 Annual Meeting of Stockholders (the "Annual Meeting") onMay 9, 2022 . Each of the proposals was approved, and each of the director nominees was elected, by the vote of the stockholders at the Annual Meeting as follows: Proposal 1: To elect the following director nominees to hold office until the 2023 Annual Meeting of Stockholders and until their respective successors are elected and qualified: For Against Abstain Broker Non-Votes Emily Peterson Alva 233,367,731 4,027,769 270,575 20,029,960 J. Kevin Buchi 200,540,414 36,874,511 251,150 20,029,960 Jeff George 199,259,620 38,156,822 249,633 20,029,960 John Kiely 193,546,651 43,852,884 266,540 20,029,960 Paul Meister 200,167,942 37,242,388 255,745 20,029,960 Ted Nark 207,399,477 30,001,444 265,154 20,029,960 Chintu Patel 236,380,089 1,187,228 98,758 20,029,960 Chirag Patel 236,348,727 1,243,120 74,228 20,029,960 Gautam Patel 233,108,078 4,481,987 76,010 20,029,960 Shlomo Yanai 236,247,636 1,285,233 133,206 20,029,960
Proposal 2: To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers:
For Against Abstain Broker Non-Votes
236,202,110 1,193,006 270,959 20,029,960
Proposal 3: To ratify the selection of
For Against Abstain Broker Non-Votes
256,967,689 253,537 474,809 0
--------------------------------------------------------------------------------
© Edgar Online, source
